Food and Drug Law Institute
FDA’s 2016 New Dietary Ingredient Draft Guidance: Promise and Challenge for Dietary Supplement Innovation
January/February 2017
On August 12, 2016, FDA issued a new Draft Guidance (Draft Guidance) on its interpretation of the New Dietary Ingredient (NDI) notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act (FDCA). The Draft Guidance contains provisions that have the potential both to facilitate and to impede innovation in the dietary supplement and functional food industries.
Contacts
Capabilities
Suggested News & Insights
What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025U.S. FDA's Adoption of ICH E6(R3) Good Clinical Practice: Key Takeaways for Sponsors and InvestigatorsDecember 4, 2025Sidley Represents PayRange in Its Acquisition of KioSoftDecember 1, 2025Sidley Represents GE HealthCare in Its US$2.3 Billion Acquisition of InteleradNovember 20, 2025Sidley Represents Nuvalent in Pricing of US$500 Million Public OfferingNovember 20, 2025Sidley Advises Rivean Capital on the Majority Investment in Engelmann Sensor GmbHNovember 20, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory